Jean-Yves Tinevez, Vanessa Ribes, Cécile St Cloment, Miguel Lopes, Philippe Daubas, Céline Bourcier de Carbon, Nathalie Duval, Benoît Robert, Génétique Moléculaire de la Morphogénèse, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Génétique Moléculaire du Développement, Imagerie Dynamique (Plate-Forme) (PFID), Institut Pasteur [Paris], Groupe Myologie, Institut de Myologie, Université Pierre et Marie Curie - Paris 6 (UPMC)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by the Institut Pasteur, the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche [Laboratoire d'Excellence Revive, Investissement d'Avenir, ANR-10-LABX-73]. M.L. was supported by grants from the Fundação para a Ciência e a Tecnologia (FCT) [SFRH/BD/36875/2007]., We are grateful to Dr A. Mansouri for the Pax7lacZ mouse strain, Prof. C. Petit and Dr L. Lepelletier for the Math1/mCherry mouse strain, Prof. J. Johnson for murine Atoh1 3′ enhancer plasmid, Prof. C. Birchmeier for anti-Olig3 antibody and Drs B. Durand and S. Rétaux for the Barhl2 and Lmx1a probes. We thank the Mouse Genetics Engineering Center (Institut Pasteur), J. F. Ouimette and C. Rougeulle for advice in setting up the ChIP experiments, C. Cimper and L. Papon for technical assistance, and I. Le Roux for critical reading of the manuscript., ANR-10-LABX-0073,REVIVE,Stem Cells in Regenerative Biology and Medicine(2010), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Institut Pasteur [Paris] (IP), Tinevez, Jean-Yves, and Laboratoires d'excellence - Stem Cells in Regenerative Biology and Medicine - - REVIVE2010 - ANR-10-LABX-0073 - LABX - VALID
Dorsal spinal neurogenesis is orchestrated by the combined action of signals secreted from the roof plate organizer and a downstream transcriptional cascade. Within this cascade, Msx1 and Msx2 , two homeodomain transcription factors (TFs), are induced earlier than bHLH neuralizing TFs. Whereas bHLH TFs have been shown to specify neuronal cell fate, the function of Msx genes remains poorly defined. We describe dramatic alterations of neuronal patterning in Msx1 / Msx2 double-mutant mouse embryos. The most dorsal spinal progenitor pool fails to express the bHLH neuralizing TF Atoh1 , which results in a lack of Lhx2- positive and Barhl2- positive dI1 interneurons. Neurog1 and Ascl1 expression territories are dorsalized, leading to ectopic dorsal differentiation of dI2 and dI3 interneurons. In proportion, the amount of Neurog1 -expressing progenitors appears unaffected, whereas the number of Ascl1- positive cells is increased. These defects occur while BMP signaling is still active in the Msx1/Msx2 mutant embryos. Cell lineage analysis and co-immunolabeling demonstrate that Atoh1-positive cells derive from progenitors expressing both Msx1 and Msx2. In vitro , Msx1 and Msx2 proteins activate Atoh1 transcription by specifically interacting with several homeodomain binding sites in the Atoh1 3′ enhancer. In vivo , Msx1 and Msx2 are required for Atoh1 3′ enhancer activity and ChIP experiments confirm Msx1 binding to this regulatory sequence. These data support a novel function of Msx1 and Msx2 as transcriptional activators. Our study provides new insights into the transcriptional control of spinal cord patterning by BMP signaling, with Msx1 and Msx2 acting upstream of Atoh1.